Generalizability of heterogeneous treatment effects based on causal forests applied to two randomized clinical trials of intensive glycemic control.

BMI, Body mass index Generalizability, Glycemic control, Causal forests, Heterogeneous treatment effects. Abbreviations: ACCORD, Action to Control Cardiovascular Risk in Diabetes Study HGI, Hemoglobin glycation index HTE, Heterogeneous treatment effects HbA1c, Hemoglobin A1c VADT, Veterans Affairs Diabetes Trial eGFR, Estimated glomerular filtration rate

Journal

Annals of epidemiology
ISSN: 1873-2585
Titre abrégé: Ann Epidemiol
Pays: United States
ID NLM: 9100013

Informations de publication

Date de publication:
01 2022
Historique:
received: 17 02 2021
revised: 04 06 2021
accepted: 09 07 2021
pubmed: 20 7 2021
medline: 22 3 2022
entrez: 19 7 2021
Statut: ppublish

Résumé

Purpose Machine learning is an attractive tool for identifying heterogeneous treatment effects (HTE) of interventions but generalizability of machine learning derived HTE remains unclear. We examined generalizability of HTE detected using causal forests in two similarly designed randomized trials in type II diabetes patients. Methods We evaluated published HTE of intensive versus standard glycemic control on all-cause mortality from the Action to Control Cardiovascular Risk in Diabetes study (ACCORD) in a second trial, the Veterans Affairs Diabetes Trial (VADT). We then applied causal forests to VADT, ACCORD, and pooled data from both studies and compared variable importance and subgroup effects across samples. Results HTE in ACCORD did not replicate in similar subgroups in VADT, but variable importance was correlated between VADT and ACCORD (Kendall's tau-b 0.75). Applying causal forests to pooled individual-level data yielded seven subgroups with similar HTE across both studies, ranging from risk difference of all-cause mortality of -3.9% (95% CI -7.0, -0.8) to 4.7% (95% CI 1.8, 7.5). Conclusions Machine learning detection of HTE subgroups from randomized trials may not generalize across study samples even when variable importance is correlated. Pooling individual-level data may overcome differences in study populations and/or differences in interventions that limit HTE generalizability.

Identifiants

pubmed: 34280545
pii: S1047-2797(21)00212-X
doi: 10.1016/j.annepidem.2021.07.003
pmc: PMC8748294
mid: NIHMS1725473
pii:
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0
Hypoglycemic Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

101-108

Subventions

Organisme : CSRD VA
ID : IK2 CX001907
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK109200
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092926
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA129102
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest relevant to the work in this study. Medications and financial support were provided by Sanofi, GlaxoSmithKline, Novo Nordisk, Roche, Kos Pharmaceuticals, Merck, and Amylin. No other potential conflicts of interest relevant to this article were reported. These companies had no role in the design of the study, in the accrual or analysis of the data, or in the preparation or approval of the manuscript.

Références

Stat Med. 2018 Oct 15;37(23):3309-3324
pubmed: 29862536
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4156-4165
pubmed: 30770453
JAMA. 2018 Apr 3;319(13):1317-1318
pubmed: 29532063
Am J Epidemiol. 2010 Jul 1;172(1):107-15
pubmed: 20547574
Am J Epidemiol. 2019 Feb 1;188(2):426-437
pubmed: 30312378
Eur J Heart Fail. 2019 Jan;21(1):74-85
pubmed: 30328654
Eur Heart J. 2017 Jun 14;38(23):1805-1814
pubmed: 27436868
Epidemiology. 2017 Jul;28(4):553-561
pubmed: 28346267
Stat Med. 2012 Jul 10;31(15):1601-16
pubmed: 22302520
Stat Med. 2018 May 20;37(11):1767-1787
pubmed: 29508417
JAMA Intern Med. 2017 Apr 1;177(4):554-560
pubmed: 28192563
BMJ. 2020 Mar 20;368:l6927
pubmed: 32198138
JAMA. 2020 Jan 28;323(4):305-306
pubmed: 31904799
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7353-60
pubmed: 27382149
Diabetes Care. 2011 Jan;34(1):34-8
pubmed: 21059830
Biometrics. 2019 Jun;75(2):685-694
pubmed: 30488513
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
Ann Intern Med. 2006 Aug 15;145(4):247-54
pubmed: 16908915
Am J Epidemiol. 2017 Oct 15;186(8):1010-1014
pubmed: 28535275
Diabetes Care. 2018 Mar;41(3):604-612
pubmed: 29279299
J Diabetes Complications. 2017 Jul;31(7):1127-1131
pubmed: 28487124
Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e005010
pubmed: 30857410
Diabetes Care. 2020 Jul;43(7):1471-1478
pubmed: 32327422
N Engl J Med. 2009 Jan 8;360(2):129-39
pubmed: 19092145
JAMA Psychiatry. 2018 Dec 1;75(12):1289-1297
pubmed: 30347013
Trials. 2018 Jul 16;19(1):382
pubmed: 30012181
Pharmacoeconomics. 2010;28(10):935-45
pubmed: 20831302
N Engl J Med. 2008 Jun 12;358(24):2560-72
pubmed: 18539916

Auteurs

Sridharan Raghavan (S)

Department of Veterans Affairs Eastern Colorado Healthcare System, Aurora, CO; Division of Hospital Medicine, University of Colorado School of Medicine, Aurora, CO; Colorado Cardiovascular Outcomes Research Consortium, Aurora, CO. Electronic address: Sridharan.raghavan@cuanschutz.edu.

Kevin Josey (K)

Department of Veterans Affairs Eastern Colorado Healthcare System, Aurora, CO; Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO.

Gideon Bahn (G)

Department of Veterans Affairs Hines VA Hospital, Hines, IL.

Domenic Reda (D)

Department of Veterans Affairs Hines VA Hospital, Hines, IL.

Sanjay Basu (S)

Center for Primary Care, Harvard Medical School, Boston, MA.

Seth A Berkowitz (SA)

Division of General Medicine and Clinical Epidemiology, University of North Carolina School of Medicine, Chapel Hill, NC; Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Nicholas Emanuele (N)

Department of Veterans Affairs Hines VA Hospital, Hines, IL.

Peter Reaven (P)

Department of Veterans Affairs Phoenix VA Medical Center, Phoenix, AZ.

Debashis Ghosh (D)

Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH